Pharmocann Global (XTAE:PMCN-M) LT-Debt-to-Total-Asset : 0.03 (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Pharmocann Global LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Pharmocann Global's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.03.

Pharmocann Global's long-term debt to total assets ratio declined from Jun. 2022 (0.11) to Dec. 2023 (0.03). It may suggest that Pharmocann Global is progressively becoming less dependent on debt to grow their business.

Pharmocann Global LT-Debt-to-Total-Asset Historical Data

The historical data trend for Pharmocann Global's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmocann Global LT-Debt-to-Total-Asset Chart

Pharmocann Global Annual Data

Trend

Dec09

Dec10

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.04

0.05

0.07

0.11

0.03

Pharmocann Global Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.11	0.13	0.11	0.05	0.03

Pharmocann Global LT-Debt-to-Total-Asset Calculation

Pharmocann Global's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0.194	/	7.102
	=	0.03

Pharmocann Global's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	0.194	/	7.102
	=

Pharmocann Global (XTAE:PMCN-M) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Pharmocann Global LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Pharmocann Global's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmocann Global (XTAE:PMCN-M) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmocann Global Ltd (XTAE:PMCN-M) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ramat Yishai, PO Box 305, Kiryat Tivon, ISR, 3601201

Website

https://www.pharmocann.co.il

Pharmocann Global Ltd is an Israel-based company engaged in producing medical-related cannabis products which include oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various types of THC/CBD strains.

Pharmocann Global (XTAE:PMCN-M) Headlines

No Headlines